 Objective, to elucidate the possible association between suicidal tendencies and psychiatric symptoms associated with anabolic androgenic steroid usage among athletes. Method, the cross-sectional study was conducted from December 2016 to July 2017 in Rolpini and Wakantanment, Pakistan, after approval from the International Islamic University, Islamabad, and comprised male athletes aged greater than 18 years. Those using androgenic anabolic steroid formed Group A, while the non-users were in Group B. In addition to demographers, data was collected using BEX scale for suicidal ideation and the symptoms checklist, 90. Data was analyzed using SPSS 22. Continue. This article was authored by Basharat Hussein, Muhammad Tayyar Kalili, and Muhammad Ather Kalili.